<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35596156</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1528-3658</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Molecular medicine (Cambridge, Mass.)</Title>
          <ISOAbbreviation>Mol Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Glabridin, a bioactive component of licorice, ameliorates diabetic nephropathy by regulating ferroptosis and the VEGF/Akt/ERK pathways.</ArticleTitle>
        <Pagination>
          <StartPage>58</StartPage>
          <MedlinePgn>58</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">58</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s10020-022-00481-w</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Glabridin (Glab) is a bioactive component of licorice that can ameliorate diabetes, but its role in diabetic nephropathy (DN) has seldom been reported. Herein, we explored the effect and underlying mechanism of Glab on DN.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The bioactive component-target network of licorice against DN was by a network pharmacology approach. The protective effect of Glab on the kidney was investigated by a high-fat diet with streptozotocin induced-diabetic rat model. High glucose-induced NRK-52E cells were used for in vitro studies. The effects of Glab on ferroptosis and VEGF/Akt/ERK pathways in DN were investigated in vivo and in vitro using qRT-PCR, WB, and IHC experiments.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Bioinformatics analysis constructed a network comprising of 10 bioactive components of licorice and 40 targets for DN. 13 matching targets of Glab were mainly involved in the VEGF signaling pathway. Glab treatment ameliorated general states and reduced FBG, HOMA-β, and HOMA-insulin index of diabetic rats. The renal pathological changes and the impaired renal function (the increased levels of Scr, BUN, UREA, KIM-1, NGAL, and TIMP-1) were also improved by Glab. Moreover, Glab repressed ferroptosis by increasing SOD and GSH activity, and GPX4, SLC7A11, and SLC3A2 expression, and decreasing MDA and iron concentrations, and TFR1 expression, in vivo and in vitro. Mechanically, Glab significantly suppressed VEGF, p-AKT, p-ERK1/2 expression in both diabetic rats and HG-induced NRK-52E cells.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study revealed protective effects of Glab on the kidney of diabetic rats, which might exert by suppressing ferroptosis and the VEGF/Akt/ERK pathway.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tan</LastName>
            <ForeName>Hongtao</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huicheng District, No. 41 Eling North Road, Huizhou, 516000, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Junxian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>The First College of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yicong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huicheng District, No. 41 Eling North Road, Huizhou, 516000, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yingshan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huicheng District, No. 41 Eling North Road, Huizhou, 516000, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhong</LastName>
            <ForeName>Yunchang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huicheng District, No. 41 Eling North Road, Huizhou, 516000, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Guangzhao</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huicheng District, No. 41 Eling North Road, Huizhou, 516000, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Lingling</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0001-7672-3780</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huicheng District, No. 41 Eling North Road, Huizhou, 516000, Guangdong, China. liu_ling_ling@sina.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yiqun</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huicheng District, No. 41 Eling North Road, Huizhou, 516000, Guangdong, China. li_yi_qun@sina.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Mol Med</MedlineTA>
        <NlmUniqueID>9501023</NlmUniqueID>
        <ISSNLinking>1076-1551</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007529">Isoflavones</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010636">Phenols</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>HOC5567T41</RegistryNumber>
          <NameOfSubstance UI="C107601">glabridin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003921" MajorTopicYN="Y">Diabetes Mellitus, Experimental</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003928" MajorTopicYN="Y">Diabetic Nephropathies</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000079403" MajorTopicYN="Y">Ferroptosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006035" MajorTopicYN="Y">Glycyrrhiza</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007529" MajorTopicYN="N">Isoflavones</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010636" MajorTopicYN="N">Phenols</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bioinformatics</Keyword>
        <Keyword MajorTopicYN="N">Diabetic nephropathy</Keyword>
        <Keyword MajorTopicYN="N">Ferroptosis</Keyword>
        <Keyword MajorTopicYN="N">Glabridin</Keyword>
        <Keyword MajorTopicYN="N">VEGF signaling pathway</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>23</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35596156</ArticleId>
        <ArticleId IdType="pmc">PMC9123664</ArticleId>
        <ArticleId IdType="doi">10.1186/s10020-022-00481-w</ArticleId>
        <ArticleId IdType="pii">10.1186/s10020-022-00481-w</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12:2032–2045. doi: 10.2215/CJN.11491116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2215/CJN.11491116</ArticleId>
            <ArticleId IdType="pmc">PMC5718284</ArticleId>
            <ArticleId IdType="pubmed">28522654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cha DR, Kang YS, Han SY, Jee YH, Han KH, Han JY, Kim YS, Kim NH. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats. J Endocrinol. 2004;183:183–194. doi: 10.1677/joe.1.05647.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1677/joe.1.05647</ArticleId>
            <ArticleId IdType="pubmed">15525586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng RX, Feng Y, Liu D, Wang ZH, Zhang JT, Chen LH, Su CJ, Wang B, Huang Y, Ji RR, Hu J, Liu T. The role of Na(v)1.7 and methylglyoxal-mediated activation of TRPA1 in itch and hypoalgesia in a murine model of type 1 diabetes. Theranostics. 2019;9:4287–4307. doi: 10.7150/thno.36077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/thno.36077</ArticleId>
            <ArticleId IdType="pmc">PMC6599654</ArticleId>
            <ArticleId IdType="pubmed">31285762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheon JH, Kim SY, Son JY, Kang YR, An JH, Kwon JH, Song HS, Moon A, Lee BM, Kim HS. Pyruvate Kinase M2: a novel biomarker for the early detection of acute kidney injury. Toxicol Res. 2016;32:47–56. doi: 10.5487/TR.2016.32.1.047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5487/TR.2016.32.1.047</ArticleId>
            <ArticleId IdType="pmc">PMC4780241</ArticleId>
            <ArticleId IdType="pubmed">26977258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chin YW, Jung HA, Liu Y, Su BN, Castoro JA, Keller WJ, Pereira MA, Kinghorn AD. Anti-oxidant constituents of the roots and stolons of licorice (Glycyrrhiza glabra) J Agric Food Chem. 2007;55:4691–4697. doi: 10.1021/jf0703553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jf0703553</ArticleId>
            <ArticleId IdType="pubmed">17516657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chromek M, Tullus K, Lundahl J, Brauner A. Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation. Infect Immun. 2004;72:82–88. doi: 10.1128/IAI.72.1.82-88.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.72.1.82-88.2004</ArticleId>
            <ArticleId IdType="pmc">PMC343974</ArticleId>
            <ArticleId IdType="pubmed">14688084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dabla PK. Renal function in diabetic nephropathy. World J Diabetes. 2010;1:48–56. doi: 10.4239/wjd.v1.i2.48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4239/wjd.v1.i2.48</ArticleId>
            <ArticleId IdType="pmc">PMC3083882</ArticleId>
            <ArticleId IdType="pubmed">21537427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014;10:9–17. doi: 10.1038/nchembio.1416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nchembio.1416</ArticleId>
            <ArticleId IdType="pubmed">24346035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Ashmawy NE, El-Zamarany EA, Khedr NF, Abd El-Fattah AI, Eltoukhy SA. Kidney injury molecule-1 (Kim-1): an early biomarker for nephropathy in type II diabetic patients. Int J Diabetes Dev Countries. 2015;35:431–438. doi: 10.1007/s13410-015-0403-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13410-015-0403-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forbes JM, Cooper ME, Oldfield MD, Thomas MC. Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol. 2003;14:S254–S258. doi: 10.1097/01.ASN.0000077413.41276.17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.ASN.0000077413.41276.17</ArticleId>
            <ArticleId IdType="pubmed">12874442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine (abingdon) 2014;42:698–702.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4282306</ArticleId>
            <ArticleId IdType="pubmed">25568613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujita H, Omori S, Ishikura K, Hida M, Awazu M. ERK and p38 mediate high-glucose-induced hypertrophy and TGF-beta expression in renal tubular cells. Am J Physiol Renal Physiol. 2004;286:F120–F126. doi: 10.1152/ajprenal.00351.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00351.2002</ArticleId>
            <ArticleId IdType="pubmed">12952860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furman BL. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc. 2021;1:e78. doi: 10.1002/cpz1.78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cpz1.78</ArticleId>
            <ArticleId IdType="pubmed">33905609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164–176. doi: 10.2337/diacare.28.1.164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diacare.28.1.164</ArticleId>
            <ArticleId IdType="pubmed">15616252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horton WB, Boler PL, Subauste AR. Diabetes mellitus and the skin: recognition and management of cutaneous manifestations. South Med J. 2016;109:636–646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27706502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang M, Zhao S, Yang S, Lin X, He X, Wei X, Song Q, Li R, Fu C, Zhang J, Zhang Z. An, “essential herbal medicine”-licorice: a review of phytochemicals and its effects in combination preparations. J Ethnopharmacol. 2020;249:112439. doi: 10.1016/j.jep.2019.112439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jep.2019.112439</ArticleId>
            <ArticleId IdType="pubmed">31811935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kashihara N, Haruna Y, Kondeti VK, Kanwar YS. Oxidative stress in diabetic nephropathy. Curr Med Chem. 2010;17:4256–4269. doi: 10.2174/092986710793348581.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/092986710793348581</ArticleId>
            <ArticleId IdType="pmc">PMC3708695</ArticleId>
            <ArticleId IdType="pubmed">20939814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kataya HH, Hamza AA, Ramadan GA, Khasawneh MA. Effect of licorice extract on the complications of diabetes nephropathy in rats. Drug Chem Toxicol. 2011;34:101–108. doi: 10.3109/01480545.2010.510524.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/01480545.2010.510524</ArticleId>
            <ArticleId IdType="pubmed">21314459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan FA, Fatima SS, Khan GM, Shahid S. Evaluation of kidney injury molecule-1 as a disease progression biomarker in diabetic nephropathy. Pak J Med Sci. 2019;35:992–996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6659046</ArticleId>
            <ArticleId IdType="pubmed">31372130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim SS, Song SH, Kim IJ, Yang JY, Lee JG, Kwak IS, Kim YK. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients. Diabetes Res Clin Pract. 2012;97:251–257. doi: 10.1016/j.diabres.2012.02.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.diabres.2012.02.019</ArticleId>
            <ArticleId IdType="pubmed">22440044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kitada M, Ogura Y, Koya D. Rodent models of diabetic nephropathy: their utility and limitations. Int J Nephrol Renovasc Dis. 2016;9:279–290. doi: 10.2147/IJNRD.S103784.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IJNRD.S103784</ArticleId>
            <ArticleId IdType="pmc">PMC5115690</ArticleId>
            <ArticleId IdType="pubmed">27881924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuhn M, von Mering C, Campillos M, Jensen LJ, Bork P. STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res. 2008;36:D684–D688. doi: 10.1093/nar/gkm795.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkm795</ArticleId>
            <ArticleId IdType="pmc">PMC2238848</ArticleId>
            <ArticleId IdType="pubmed">18084021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kundu A, Dey P, Sarkar P, Karmakar S, Tae IH, Kim KS, Park JH, Lee SH, Lee BM, Renthlei L, Puia Z, Kim HS. Protective effects of Croton hookeri on streptozotocin-induced diabetic nephropathy. Food Chem Toxicol. 2020;135:110873. doi: 10.1016/j.fct.2019.110873.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fct.2019.110873</ArticleId>
            <ArticleId IdType="pubmed">31600566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, Yoshioka T, Ogawa Y, Imamaki H, Kusakabe T, Ebihara K, Omata M, Satoh N, Sugawara A, Barasch J, Nakao K. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int. 2009;75:285–294. doi: 10.1038/ki.2008.499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2008.499</ArticleId>
            <ArticleId IdType="pubmed">19148153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lang J, Shlipak MG. Kidney disease, income, and life expectancy. Am J Kidney Dis. 2016;68:674–676. doi: 10.1053/j.ajkd.2016.07.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.ajkd.2016.07.004</ArticleId>
            <ArticleId IdType="pubmed">27772630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee EK, Shin YJ, Park EY, Kim ND, Moon A, Kwack SJ, Son JY, Kacew S, Lee BM, Bae ON, Kim HS. Selenium-binding protein 1: a sensitive urinary biomarker to detect heavy metal-induced nephrotoxicity. Arch Toxicol. 2017;91:1635–1648. doi: 10.1007/s00204-016-1832-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00204-016-1832-6</ArticleId>
            <ArticleId IdType="pubmed">27578022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M, Smith SB, Ganapathy V, Maher P. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18:522–555. doi: 10.1089/ars.2011.4391.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2011.4391</ArticleId>
            <ArticleId IdType="pmc">PMC3545354</ArticleId>
            <ArticleId IdType="pubmed">22667998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li S, Zheng L, Zhang J, Liu X, Wu Z. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy. Free Radic Biol Med. 2021;162:435–449. doi: 10.1016/j.freeradbiomed.2020.10.323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.10.323</ArticleId>
            <ArticleId IdType="pubmed">33152439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li C-x, Li T-h, Zhu M, Lai J, Wu Z-p. Pharmacological properties of glabridin (a flavonoid extracted from licorice): a comprehensive review. J Funct Foods. 2021;85:104638. doi: 10.1016/j.jff.2021.104638.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jff.2021.104638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang S, Cai GY, Chen XM. Clinical and pathological factors associated with progression of diabetic nephropathy. Nephrology (carlton) 2017;22(Suppl 4):14–19. doi: 10.1111/nep.13182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/nep.13182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim A. Diabetic nephropathy—complications and treatment. Int J Nephrol Renovasc Dis. 2014;7:361–381. doi: 10.2147/IJNRD.S40172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IJNRD.S40172</ArticleId>
            <ArticleId IdType="pmc">PMC4206379</ArticleId>
            <ArticleId IdType="pubmed">25342915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Z, Guo F, Wang Y, Li C, Zhang X, Li H, Diao L, Gu J, Wang W, Li D, He F. BATMAN-TCM: a bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine. Sci Rep. 2016;6:21146. doi: 10.1038/srep21146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep21146</ArticleId>
            <ArticleId IdType="pmc">PMC4754750</ArticleId>
            <ArticleId IdType="pubmed">26879404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId>
            <ArticleId IdType="pubmed">11846609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma ST, Liu DL, Deng JJ, Niu R, Liu RB. Effect of arctiin on glomerular filtration barrier damage in STZ-induced diabetic nephropathy rats. Phytother Res. 2013;27:1474–1480. doi: 10.1002/ptr.4884.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ptr.4884</ArticleId>
            <ArticleId IdType="pubmed">23147865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mage M, Pécher C, Neau E, Cellier E, Dos Reiss ML, Schanstra JP, Couture R, Bascands JL, Girolami JP. Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation. Can J Physiol Pharmacol. 2002;80:328–333. doi: 10.1139/y02-024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1139/y02-024</ArticleId>
            <ArticleId IdType="pubmed">12025968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. doi: 10.1007/BF00280883.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00280883</ArticleId>
            <ArticleId IdType="pubmed">3899825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piñero J, Bravo À, Queralt-Rosinach N, Gutiérrez-Sacristán A, Deu-Pons J, Centeno E, García-García J, Sanz F, Furlong LI. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2017;45:D833–D839. doi: 10.1093/nar/gkw943.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkw943</ArticleId>
            <ArticleId IdType="pmc">PMC5210640</ArticleId>
            <ArticleId IdType="pubmed">27924018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, Xu X, Li Y, Wang Y, Yang L. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13. doi: 10.1186/1758-2946-6-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1758-2946-6-13</ArticleId>
            <ArticleId IdType="pmc">PMC4001360</ArticleId>
            <ArticleId IdType="pubmed">24735618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shlipak M. Diabetic nephropathy: preventing progression. BMJ Clin Evid. 2010;2010:0606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3217768</ArticleId>
            <ArticleId IdType="pubmed">21418671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sidorenkov G, Navis G. Safety of ACE inhibitor therapies in patients with chronic kidney disease. Expert Opin Drug Saf. 2014;13:1383–1395. doi: 10.1517/14740338.2014.951328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/14740338.2014.951328</ArticleId>
            <ArticleId IdType="pubmed">25148900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sieber M, Hoffmann D, Adler M, Vaidya VS, Clement M, Bonventre JV, Zidek N, Rached E, Amberg A, Callanan JJ, Dekant W, Mally A. Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity. Toxicol Sci. 2009;109:336–349. doi: 10.1093/toxsci/kfp070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/toxsci/kfp070</ArticleId>
            <ArticleId IdType="pmc">PMC4830225</ArticleId>
            <ArticleId IdType="pubmed">19349640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh DK, Winocour P, Farrington K. Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol. 2011;7:176–184. doi: 10.1038/nrendo.2010.212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrendo.2010.212</ArticleId>
            <ArticleId IdType="pubmed">21151200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sohn E, Kim J, Kim CS, Lee YM, Jo K, Shin SD, Kim JH, Kim JS. The extract of Litsea japonica reduced the development of diabetic nephropathy via the inhibition of advanced glycation end products accumulation in db/db mice. Evid Based Complement Alternat Med. 2013;2013:769416. doi: 10.1155/2013/769416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/769416</ArticleId>
            <ArticleId IdType="pmc">PMC3678449</ArticleId>
            <ArticleId IdType="pubmed">23781268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Stein TI, Nudel R, Lieder I, Mazor Y, Kaplan S, Dahary D, Warshawsky D, Guan-Golan Y, Kohn A, Rappaport N, Safran M, Lancet D. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016;54:1.30.1–1.30.33. doi: 10.1002/cpbi.5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cpbi.5</ArticleId>
            <ArticleId IdType="pubmed">27322403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su G, Morris JH, Demchak B, Bader GD. Biological network exploration with Cytoscape 3. Curr Protoc Bioinformatics. 2014;47:8.13.1–24. doi: 10.1002/0471250953.bi0813s47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/0471250953.bi0813s47</ArticleId>
            <ArticleId IdType="pmc">PMC4174321</ArticleId>
            <ArticleId IdType="pubmed">25199793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thakur V, Nargis S, Gonzalez M, Pradhan S, Terreros D, Chattopadhyay M. Role of glycyrrhizin in the reduction of inflammation in diabetic kidney disease. Nephron. 2017;137:137–147. doi: 10.1159/000477820.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000477820</ArticleId>
            <ArticleId IdType="pubmed">28641285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tremolada G, Lattanzio R, Mazzolari G, Zerbini G. The therapeutic potential of VEGF inhibition in diabetic microvascular complications. Am J Cardiovasc Drugs. 2007;7:393–398. doi: 10.2165/00129784-200707060-00002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2165/00129784-200707060-00002</ArticleId>
            <ArticleId IdType="pubmed">18076206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. 2011;17:1217–1220. doi: 10.1038/nm.2471.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2471</ArticleId>
            <ArticleId IdType="pubmed">21989013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tufro A, Veron D. VEGF and podocytes in diabetic nephropathy. Semin Nephrol. 2012;32:385–393. doi: 10.1016/j.semnephrol.2012.06.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semnephrol.2012.06.010</ArticleId>
            <ArticleId IdType="pmc">PMC3438453</ArticleId>
            <ArticleId IdType="pubmed">22958493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol. 2001;12:993–1000. doi: 10.1681/ASN.V125993.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.V125993</ArticleId>
            <ArticleId IdType="pubmed">11316858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487–1495. doi: 10.2337/diacare.27.6.1487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diacare.27.6.1487</ArticleId>
            <ArticleId IdType="pubmed">15161807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Chen Q, Shi C, Jiao F, Gong Z. Mechanism of glycyrrhizin on ferroptosis during acute liver failure by inhibiting oxidative stress. Mol Med Rep. 2019;20:4081–4090.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6797988</ArticleId>
            <ArticleId IdType="pubmed">31545489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Bi R, Quan F, Cao Q, Lin Y, Yue C, Cui X, Yang H, Gao X, Zhang D. Ferroptosis involves in renal tubular cell death in diabetic nephropathy. Eur J Pharmacol. 2020;888:173574. doi: 10.1016/j.ejphar.2020.173574.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejphar.2020.173574</ArticleId>
            <ArticleId IdType="pubmed">32976829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wen Y, Chen H, Zhang L, Wu M, Zhang F, Yang D, Shen J, Chen J. Glycyrrhetinic acid induces oxidative/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and depriving glutathione in triple-negative breast cancer cells. Free Radic Biol Med. 2021;173:41–51. doi: 10.1016/j.freeradbiomed.2021.07.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2021.07.019</ArticleId>
            <ArticleId IdType="pubmed">34271106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu F, Jin Z, Jin J. Hypoglycemic effects of glabridin, a polyphenolic flavonoid from licorice, in an animal model of diabetes mellitus. Mol Med Rep. 2013;7:1278–1282. doi: 10.3892/mmr.2013.1330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/mmr.2013.1330</ArticleId>
            <ArticleId IdType="pubmed">23426874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu K, Guo L, Bu H, Wang H. Daphnetin inhibits high glucose-induced extracellular matrix accumulation, oxidative stress and inflammation in human glomerular mesangial cells. J Pharmacol Sci. 2019;139:91–97. doi: 10.1016/j.jphs.2018.11.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jphs.2018.11.013</ArticleId>
            <ArticleId IdType="pubmed">30595336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamagishi S, Matsui T. Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longev. 2010;3:101–108. doi: 10.4161/oxim.3.2.11148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/oxim.3.2.11148</ArticleId>
            <ArticleId IdType="pmc">PMC2952094</ArticleId>
            <ArticleId IdType="pubmed">20716934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–287. doi: 10.1089/omi.2011.0118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId>
            <ArticleId IdType="pmc">PMC3339379</ArticleId>
            <ArticleId IdType="pubmed">22455463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang TT, Jiang JG. Active ingredients of traditional Chinese medicine in the treatment of diabetes and diabetic complications. Expert Opin Investig Drugs. 2012;21:1625–1642. doi: 10.1517/13543784.2012.713937.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/13543784.2012.713937</ArticleId>
            <ArticleId IdType="pubmed">22862558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X, Li X. Abnormal iron and lipid metabolism mediated ferroptosis in kidney diseases and its therapeutic potential. Metabolites. 2022;12:58. doi: 10.3390/metabo12010058.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/metabo12010058</ArticleId>
            <ArticleId IdType="pmc">PMC8779729</ArticleId>
            <ArticleId IdType="pubmed">35050181</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35596156</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1528-3658</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Molecular medicine (Cambridge, Mass.)</Title>
          <ISOAbbreviation>Mol Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Glabridin, a bioactive component of licorice, ameliorates diabetic nephropathy by regulating ferroptosis and the VEGF/Akt/ERK pathways.</ArticleTitle>
        <Pagination>
          <StartPage>58</StartPage>
          <MedlinePgn>58</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">58</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s10020-022-00481-w</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Glabridin (Glab) is a bioactive component of licorice that can ameliorate diabetes, but its role in diabetic nephropathy (DN) has seldom been reported. Herein, we explored the effect and underlying mechanism of Glab on DN.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The bioactive component-target network of licorice against DN was by a network pharmacology approach. The protective effect of Glab on the kidney was investigated by a high-fat diet with streptozotocin induced-diabetic rat model. High glucose-induced NRK-52E cells were used for in vitro studies. The effects of Glab on ferroptosis and VEGF/Akt/ERK pathways in DN were investigated in vivo and in vitro using qRT-PCR, WB, and IHC experiments.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Bioinformatics analysis constructed a network comprising of 10 bioactive components of licorice and 40 targets for DN. 13 matching targets of Glab were mainly involved in the VEGF signaling pathway. Glab treatment ameliorated general states and reduced FBG, HOMA-β, and HOMA-insulin index of diabetic rats. The renal pathological changes and the impaired renal function (the increased levels of Scr, BUN, UREA, KIM-1, NGAL, and TIMP-1) were also improved by Glab. Moreover, Glab repressed ferroptosis by increasing SOD and GSH activity, and GPX4, SLC7A11, and SLC3A2 expression, and decreasing MDA and iron concentrations, and TFR1 expression, in vivo and in vitro. Mechanically, Glab significantly suppressed VEGF, p-AKT, p-ERK1/2 expression in both diabetic rats and HG-induced NRK-52E cells.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study revealed protective effects of Glab on the kidney of diabetic rats, which might exert by suppressing ferroptosis and the VEGF/Akt/ERK pathway.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tan</LastName>
            <ForeName>Hongtao</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huicheng District, No. 41 Eling North Road, Huizhou, 516000, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Junxian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>The First College of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yicong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huicheng District, No. 41 Eling North Road, Huizhou, 516000, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yingshan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huicheng District, No. 41 Eling North Road, Huizhou, 516000, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhong</LastName>
            <ForeName>Yunchang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huicheng District, No. 41 Eling North Road, Huizhou, 516000, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Guangzhao</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huicheng District, No. 41 Eling North Road, Huizhou, 516000, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Lingling</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0001-7672-3780</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huicheng District, No. 41 Eling North Road, Huizhou, 516000, Guangdong, China. liu_ling_ling@sina.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yiqun</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huicheng District, No. 41 Eling North Road, Huizhou, 516000, Guangdong, China. li_yi_qun@sina.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Mol Med</MedlineTA>
        <NlmUniqueID>9501023</NlmUniqueID>
        <ISSNLinking>1076-1551</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007529">Isoflavones</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010636">Phenols</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>HOC5567T41</RegistryNumber>
          <NameOfSubstance UI="C107601">glabridin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003921" MajorTopicYN="Y">Diabetes Mellitus, Experimental</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003928" MajorTopicYN="Y">Diabetic Nephropathies</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000079403" MajorTopicYN="Y">Ferroptosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006035" MajorTopicYN="Y">Glycyrrhiza</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007529" MajorTopicYN="N">Isoflavones</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010636" MajorTopicYN="N">Phenols</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bioinformatics</Keyword>
        <Keyword MajorTopicYN="N">Diabetic nephropathy</Keyword>
        <Keyword MajorTopicYN="N">Ferroptosis</Keyword>
        <Keyword MajorTopicYN="N">Glabridin</Keyword>
        <Keyword MajorTopicYN="N">VEGF signaling pathway</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>23</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35596156</ArticleId>
        <ArticleId IdType="pmc">PMC9123664</ArticleId>
        <ArticleId IdType="doi">10.1186/s10020-022-00481-w</ArticleId>
        <ArticleId IdType="pii">10.1186/s10020-022-00481-w</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12:2032–2045. doi: 10.2215/CJN.11491116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2215/CJN.11491116</ArticleId>
            <ArticleId IdType="pmc">PMC5718284</ArticleId>
            <ArticleId IdType="pubmed">28522654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cha DR, Kang YS, Han SY, Jee YH, Han KH, Han JY, Kim YS, Kim NH. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats. J Endocrinol. 2004;183:183–194. doi: 10.1677/joe.1.05647.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1677/joe.1.05647</ArticleId>
            <ArticleId IdType="pubmed">15525586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng RX, Feng Y, Liu D, Wang ZH, Zhang JT, Chen LH, Su CJ, Wang B, Huang Y, Ji RR, Hu J, Liu T. The role of Na(v)1.7 and methylglyoxal-mediated activation of TRPA1 in itch and hypoalgesia in a murine model of type 1 diabetes. Theranostics. 2019;9:4287–4307. doi: 10.7150/thno.36077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/thno.36077</ArticleId>
            <ArticleId IdType="pmc">PMC6599654</ArticleId>
            <ArticleId IdType="pubmed">31285762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheon JH, Kim SY, Son JY, Kang YR, An JH, Kwon JH, Song HS, Moon A, Lee BM, Kim HS. Pyruvate Kinase M2: a novel biomarker for the early detection of acute kidney injury. Toxicol Res. 2016;32:47–56. doi: 10.5487/TR.2016.32.1.047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5487/TR.2016.32.1.047</ArticleId>
            <ArticleId IdType="pmc">PMC4780241</ArticleId>
            <ArticleId IdType="pubmed">26977258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chin YW, Jung HA, Liu Y, Su BN, Castoro JA, Keller WJ, Pereira MA, Kinghorn AD. Anti-oxidant constituents of the roots and stolons of licorice (Glycyrrhiza glabra) J Agric Food Chem. 2007;55:4691–4697. doi: 10.1021/jf0703553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jf0703553</ArticleId>
            <ArticleId IdType="pubmed">17516657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chromek M, Tullus K, Lundahl J, Brauner A. Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation. Infect Immun. 2004;72:82–88. doi: 10.1128/IAI.72.1.82-88.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.72.1.82-88.2004</ArticleId>
            <ArticleId IdType="pmc">PMC343974</ArticleId>
            <ArticleId IdType="pubmed">14688084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dabla PK. Renal function in diabetic nephropathy. World J Diabetes. 2010;1:48–56. doi: 10.4239/wjd.v1.i2.48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4239/wjd.v1.i2.48</ArticleId>
            <ArticleId IdType="pmc">PMC3083882</ArticleId>
            <ArticleId IdType="pubmed">21537427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014;10:9–17. doi: 10.1038/nchembio.1416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nchembio.1416</ArticleId>
            <ArticleId IdType="pubmed">24346035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Ashmawy NE, El-Zamarany EA, Khedr NF, Abd El-Fattah AI, Eltoukhy SA. Kidney injury molecule-1 (Kim-1): an early biomarker for nephropathy in type II diabetic patients. Int J Diabetes Dev Countries. 2015;35:431–438. doi: 10.1007/s13410-015-0403-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13410-015-0403-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forbes JM, Cooper ME, Oldfield MD, Thomas MC. Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol. 2003;14:S254–S258. doi: 10.1097/01.ASN.0000077413.41276.17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.ASN.0000077413.41276.17</ArticleId>
            <ArticleId IdType="pubmed">12874442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine (abingdon) 2014;42:698–702.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4282306</ArticleId>
            <ArticleId IdType="pubmed">25568613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujita H, Omori S, Ishikura K, Hida M, Awazu M. ERK and p38 mediate high-glucose-induced hypertrophy and TGF-beta expression in renal tubular cells. Am J Physiol Renal Physiol. 2004;286:F120–F126. doi: 10.1152/ajprenal.00351.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00351.2002</ArticleId>
            <ArticleId IdType="pubmed">12952860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furman BL. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc. 2021;1:e78. doi: 10.1002/cpz1.78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cpz1.78</ArticleId>
            <ArticleId IdType="pubmed">33905609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164–176. doi: 10.2337/diacare.28.1.164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diacare.28.1.164</ArticleId>
            <ArticleId IdType="pubmed">15616252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horton WB, Boler PL, Subauste AR. Diabetes mellitus and the skin: recognition and management of cutaneous manifestations. South Med J. 2016;109:636–646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27706502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang M, Zhao S, Yang S, Lin X, He X, Wei X, Song Q, Li R, Fu C, Zhang J, Zhang Z. An, “essential herbal medicine”-licorice: a review of phytochemicals and its effects in combination preparations. J Ethnopharmacol. 2020;249:112439. doi: 10.1016/j.jep.2019.112439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jep.2019.112439</ArticleId>
            <ArticleId IdType="pubmed">31811935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kashihara N, Haruna Y, Kondeti VK, Kanwar YS. Oxidative stress in diabetic nephropathy. Curr Med Chem. 2010;17:4256–4269. doi: 10.2174/092986710793348581.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/092986710793348581</ArticleId>
            <ArticleId IdType="pmc">PMC3708695</ArticleId>
            <ArticleId IdType="pubmed">20939814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kataya HH, Hamza AA, Ramadan GA, Khasawneh MA. Effect of licorice extract on the complications of diabetes nephropathy in rats. Drug Chem Toxicol. 2011;34:101–108. doi: 10.3109/01480545.2010.510524.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/01480545.2010.510524</ArticleId>
            <ArticleId IdType="pubmed">21314459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan FA, Fatima SS, Khan GM, Shahid S. Evaluation of kidney injury molecule-1 as a disease progression biomarker in diabetic nephropathy. Pak J Med Sci. 2019;35:992–996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6659046</ArticleId>
            <ArticleId IdType="pubmed">31372130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim SS, Song SH, Kim IJ, Yang JY, Lee JG, Kwak IS, Kim YK. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients. Diabetes Res Clin Pract. 2012;97:251–257. doi: 10.1016/j.diabres.2012.02.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.diabres.2012.02.019</ArticleId>
            <ArticleId IdType="pubmed">22440044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kitada M, Ogura Y, Koya D. Rodent models of diabetic nephropathy: their utility and limitations. Int J Nephrol Renovasc Dis. 2016;9:279–290. doi: 10.2147/IJNRD.S103784.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IJNRD.S103784</ArticleId>
            <ArticleId IdType="pmc">PMC5115690</ArticleId>
            <ArticleId IdType="pubmed">27881924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuhn M, von Mering C, Campillos M, Jensen LJ, Bork P. STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res. 2008;36:D684–D688. doi: 10.1093/nar/gkm795.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkm795</ArticleId>
            <ArticleId IdType="pmc">PMC2238848</ArticleId>
            <ArticleId IdType="pubmed">18084021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kundu A, Dey P, Sarkar P, Karmakar S, Tae IH, Kim KS, Park JH, Lee SH, Lee BM, Renthlei L, Puia Z, Kim HS. Protective effects of Croton hookeri on streptozotocin-induced diabetic nephropathy. Food Chem Toxicol. 2020;135:110873. doi: 10.1016/j.fct.2019.110873.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fct.2019.110873</ArticleId>
            <ArticleId IdType="pubmed">31600566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, Yoshioka T, Ogawa Y, Imamaki H, Kusakabe T, Ebihara K, Omata M, Satoh N, Sugawara A, Barasch J, Nakao K. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int. 2009;75:285–294. doi: 10.1038/ki.2008.499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2008.499</ArticleId>
            <ArticleId IdType="pubmed">19148153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lang J, Shlipak MG. Kidney disease, income, and life expectancy. Am J Kidney Dis. 2016;68:674–676. doi: 10.1053/j.ajkd.2016.07.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.ajkd.2016.07.004</ArticleId>
            <ArticleId IdType="pubmed">27772630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee EK, Shin YJ, Park EY, Kim ND, Moon A, Kwack SJ, Son JY, Kacew S, Lee BM, Bae ON, Kim HS. Selenium-binding protein 1: a sensitive urinary biomarker to detect heavy metal-induced nephrotoxicity. Arch Toxicol. 2017;91:1635–1648. doi: 10.1007/s00204-016-1832-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00204-016-1832-6</ArticleId>
            <ArticleId IdType="pubmed">27578022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M, Smith SB, Ganapathy V, Maher P. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18:522–555. doi: 10.1089/ars.2011.4391.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2011.4391</ArticleId>
            <ArticleId IdType="pmc">PMC3545354</ArticleId>
            <ArticleId IdType="pubmed">22667998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li S, Zheng L, Zhang J, Liu X, Wu Z. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy. Free Radic Biol Med. 2021;162:435–449. doi: 10.1016/j.freeradbiomed.2020.10.323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.10.323</ArticleId>
            <ArticleId IdType="pubmed">33152439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li C-x, Li T-h, Zhu M, Lai J, Wu Z-p. Pharmacological properties of glabridin (a flavonoid extracted from licorice): a comprehensive review. J Funct Foods. 2021;85:104638. doi: 10.1016/j.jff.2021.104638.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jff.2021.104638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang S, Cai GY, Chen XM. Clinical and pathological factors associated with progression of diabetic nephropathy. Nephrology (carlton) 2017;22(Suppl 4):14–19. doi: 10.1111/nep.13182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/nep.13182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim A. Diabetic nephropathy—complications and treatment. Int J Nephrol Renovasc Dis. 2014;7:361–381. doi: 10.2147/IJNRD.S40172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IJNRD.S40172</ArticleId>
            <ArticleId IdType="pmc">PMC4206379</ArticleId>
            <ArticleId IdType="pubmed">25342915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Z, Guo F, Wang Y, Li C, Zhang X, Li H, Diao L, Gu J, Wang W, Li D, He F. BATMAN-TCM: a bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine. Sci Rep. 2016;6:21146. doi: 10.1038/srep21146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep21146</ArticleId>
            <ArticleId IdType="pmc">PMC4754750</ArticleId>
            <ArticleId IdType="pubmed">26879404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId>
            <ArticleId IdType="pubmed">11846609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma ST, Liu DL, Deng JJ, Niu R, Liu RB. Effect of arctiin on glomerular filtration barrier damage in STZ-induced diabetic nephropathy rats. Phytother Res. 2013;27:1474–1480. doi: 10.1002/ptr.4884.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ptr.4884</ArticleId>
            <ArticleId IdType="pubmed">23147865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mage M, Pécher C, Neau E, Cellier E, Dos Reiss ML, Schanstra JP, Couture R, Bascands JL, Girolami JP. Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation. Can J Physiol Pharmacol. 2002;80:328–333. doi: 10.1139/y02-024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1139/y02-024</ArticleId>
            <ArticleId IdType="pubmed">12025968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. doi: 10.1007/BF00280883.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00280883</ArticleId>
            <ArticleId IdType="pubmed">3899825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piñero J, Bravo À, Queralt-Rosinach N, Gutiérrez-Sacristán A, Deu-Pons J, Centeno E, García-García J, Sanz F, Furlong LI. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2017;45:D833–D839. doi: 10.1093/nar/gkw943.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkw943</ArticleId>
            <ArticleId IdType="pmc">PMC5210640</ArticleId>
            <ArticleId IdType="pubmed">27924018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, Xu X, Li Y, Wang Y, Yang L. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13. doi: 10.1186/1758-2946-6-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1758-2946-6-13</ArticleId>
            <ArticleId IdType="pmc">PMC4001360</ArticleId>
            <ArticleId IdType="pubmed">24735618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shlipak M. Diabetic nephropathy: preventing progression. BMJ Clin Evid. 2010;2010:0606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3217768</ArticleId>
            <ArticleId IdType="pubmed">21418671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sidorenkov G, Navis G. Safety of ACE inhibitor therapies in patients with chronic kidney disease. Expert Opin Drug Saf. 2014;13:1383–1395. doi: 10.1517/14740338.2014.951328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/14740338.2014.951328</ArticleId>
            <ArticleId IdType="pubmed">25148900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sieber M, Hoffmann D, Adler M, Vaidya VS, Clement M, Bonventre JV, Zidek N, Rached E, Amberg A, Callanan JJ, Dekant W, Mally A. Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity. Toxicol Sci. 2009;109:336–349. doi: 10.1093/toxsci/kfp070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/toxsci/kfp070</ArticleId>
            <ArticleId IdType="pmc">PMC4830225</ArticleId>
            <ArticleId IdType="pubmed">19349640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh DK, Winocour P, Farrington K. Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol. 2011;7:176–184. doi: 10.1038/nrendo.2010.212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrendo.2010.212</ArticleId>
            <ArticleId IdType="pubmed">21151200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sohn E, Kim J, Kim CS, Lee YM, Jo K, Shin SD, Kim JH, Kim JS. The extract of Litsea japonica reduced the development of diabetic nephropathy via the inhibition of advanced glycation end products accumulation in db/db mice. Evid Based Complement Alternat Med. 2013;2013:769416. doi: 10.1155/2013/769416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/769416</ArticleId>
            <ArticleId IdType="pmc">PMC3678449</ArticleId>
            <ArticleId IdType="pubmed">23781268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Stein TI, Nudel R, Lieder I, Mazor Y, Kaplan S, Dahary D, Warshawsky D, Guan-Golan Y, Kohn A, Rappaport N, Safran M, Lancet D. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016;54:1.30.1–1.30.33. doi: 10.1002/cpbi.5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cpbi.5</ArticleId>
            <ArticleId IdType="pubmed">27322403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su G, Morris JH, Demchak B, Bader GD. Biological network exploration with Cytoscape 3. Curr Protoc Bioinformatics. 2014;47:8.13.1–24. doi: 10.1002/0471250953.bi0813s47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/0471250953.bi0813s47</ArticleId>
            <ArticleId IdType="pmc">PMC4174321</ArticleId>
            <ArticleId IdType="pubmed">25199793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thakur V, Nargis S, Gonzalez M, Pradhan S, Terreros D, Chattopadhyay M. Role of glycyrrhizin in the reduction of inflammation in diabetic kidney disease. Nephron. 2017;137:137–147. doi: 10.1159/000477820.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000477820</ArticleId>
            <ArticleId IdType="pubmed">28641285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tremolada G, Lattanzio R, Mazzolari G, Zerbini G. The therapeutic potential of VEGF inhibition in diabetic microvascular complications. Am J Cardiovasc Drugs. 2007;7:393–398. doi: 10.2165/00129784-200707060-00002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2165/00129784-200707060-00002</ArticleId>
            <ArticleId IdType="pubmed">18076206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. 2011;17:1217–1220. doi: 10.1038/nm.2471.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2471</ArticleId>
            <ArticleId IdType="pubmed">21989013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tufro A, Veron D. VEGF and podocytes in diabetic nephropathy. Semin Nephrol. 2012;32:385–393. doi: 10.1016/j.semnephrol.2012.06.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semnephrol.2012.06.010</ArticleId>
            <ArticleId IdType="pmc">PMC3438453</ArticleId>
            <ArticleId IdType="pubmed">22958493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol. 2001;12:993–1000. doi: 10.1681/ASN.V125993.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.V125993</ArticleId>
            <ArticleId IdType="pubmed">11316858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487–1495. doi: 10.2337/diacare.27.6.1487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diacare.27.6.1487</ArticleId>
            <ArticleId IdType="pubmed">15161807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Chen Q, Shi C, Jiao F, Gong Z. Mechanism of glycyrrhizin on ferroptosis during acute liver failure by inhibiting oxidative stress. Mol Med Rep. 2019;20:4081–4090.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6797988</ArticleId>
            <ArticleId IdType="pubmed">31545489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Bi R, Quan F, Cao Q, Lin Y, Yue C, Cui X, Yang H, Gao X, Zhang D. Ferroptosis involves in renal tubular cell death in diabetic nephropathy. Eur J Pharmacol. 2020;888:173574. doi: 10.1016/j.ejphar.2020.173574.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejphar.2020.173574</ArticleId>
            <ArticleId IdType="pubmed">32976829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wen Y, Chen H, Zhang L, Wu M, Zhang F, Yang D, Shen J, Chen J. Glycyrrhetinic acid induces oxidative/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and depriving glutathione in triple-negative breast cancer cells. Free Radic Biol Med. 2021;173:41–51. doi: 10.1016/j.freeradbiomed.2021.07.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2021.07.019</ArticleId>
            <ArticleId IdType="pubmed">34271106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu F, Jin Z, Jin J. Hypoglycemic effects of glabridin, a polyphenolic flavonoid from licorice, in an animal model of diabetes mellitus. Mol Med Rep. 2013;7:1278–1282. doi: 10.3892/mmr.2013.1330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/mmr.2013.1330</ArticleId>
            <ArticleId IdType="pubmed">23426874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu K, Guo L, Bu H, Wang H. Daphnetin inhibits high glucose-induced extracellular matrix accumulation, oxidative stress and inflammation in human glomerular mesangial cells. J Pharmacol Sci. 2019;139:91–97. doi: 10.1016/j.jphs.2018.11.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jphs.2018.11.013</ArticleId>
            <ArticleId IdType="pubmed">30595336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamagishi S, Matsui T. Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longev. 2010;3:101–108. doi: 10.4161/oxim.3.2.11148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/oxim.3.2.11148</ArticleId>
            <ArticleId IdType="pmc">PMC2952094</ArticleId>
            <ArticleId IdType="pubmed">20716934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–287. doi: 10.1089/omi.2011.0118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId>
            <ArticleId IdType="pmc">PMC3339379</ArticleId>
            <ArticleId IdType="pubmed">22455463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang TT, Jiang JG. Active ingredients of traditional Chinese medicine in the treatment of diabetes and diabetic complications. Expert Opin Investig Drugs. 2012;21:1625–1642. doi: 10.1517/13543784.2012.713937.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/13543784.2012.713937</ArticleId>
            <ArticleId IdType="pubmed">22862558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X, Li X. Abnormal iron and lipid metabolism mediated ferroptosis in kidney diseases and its therapeutic potential. Metabolites. 2022;12:58. doi: 10.3390/metabo12010058.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/metabo12010058</ArticleId>
            <ArticleId IdType="pmc">PMC8779729</ArticleId>
            <ArticleId IdType="pubmed">35050181</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
